<div id="readability-page-1"><div><p>Fujian Cosunter Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2025. For the nine months, the company reported sales was CNY 315.84 million compared to CNY 326.32 million a year ago. Net loss was CNY 111.58 million compared to CNY 70.64 million a year ago.</p><p>Basic loss per share from continuing operations was CNY 0.7006 compared to CNY 0.4435 a year ago. Diluted loss per share from continuing operations was CNY 0.7006 compared to CNY 0.4435 a year ago.</p></div></div>

廣生堂

<p>福建廣生堂藥業有限公司公佈了截至 2025 年 9 月 30 日的九個月財報。該公司在這九個月內的銷售額為 3.1584 億元人民幣，而去年同期為 3.2632 億元人民幣。淨虧損為 1.1158 億元人民幣，而去年同期為 7064 萬元人民幣。持續經營業務的基本每股虧損為 0.7006 元人民幣，而去年同期為 0.4435 元人民幣。持續經營業務的攤薄每股虧損為 0.7006 元人民幣，而去年同期為 0.4435 元人民幣</p>

福建廣生堂藥業股份有限公司公佈了截至2025年9月30日的九個月的財務業績